Biomotion Sciences Warrant
Price & Volume
Stats
See more52W Range | $0.01-$0.11 |
Shares Short | 4,592 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $0 |
News
See moreYahoo Finance • 2 months ago
Silexion Therapeutics shareholders approve increase in authorized share capital
About
CEO | Mr. Ilan Hadar M.B.A. |
CFO | Ms. Mirit Horenshtein Hadar |
Address | The Goldyne Savad Inst. of Gene Therapy, Jerusalem, Israel, 9112001 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 11 |
